Fund Holdings — ORACLE INVESTMENT MANAGEMENT INC

Total Portfolio Value:
$148.94M
Total Bought:
$13.94M
Total Sold:
$51.12M
Net Transaction:
-$37.17M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
GeneDx Holdings Corp.CL A(WGS)1,045,7681,023,468-22,300$44.38M$78.66M52.82%+$34.28M
Biohaven Ltd.(BHVN)705,250851,770+146,520$35.24M$31.81M21.36%-$3.43M
Ardelyx Inc1,369,2002,089,431+720,231$9.43M$10.59M7.11%+$1.16M
Springworks Therapeutics Inc34,200254,773+220,573$1.10M$9.20M6.18%+$8.11M
QuidelOrtho Corporation(QDEL)118,291118,2910$5.39M$5.27M3.54%-$124.2K
BioCryst Pharmaceuticals, Inc.(BCRX)535,558535,5580$4.07M$4.03M2.70%-$42.8K
Forian Inc
COM
1,356,1071,366,107+10,000$2.93M$2.81M1.89%-$115.0K
Palantir Technologies Inc.CL A(PLTR)27,50028,500+1,000$1.02M$2.16M1.45%+$1.13M
CAVA Group, Inc.(CAVA)18,60018,6000$2.30M$2.10M1.41%-$205.5K
Phathom Pharmaceuticals, Inc.(PHAT)749,487145,064-604,423$13.55M$1.18M0.79%-$12.37M
Pacific Biosciences of California, Inc.(PACB)727,877279,638-448,239$1.24M$511.7K0.34%-$725.7K
Biogen Inc.(BIIB)2,4122,4120$467.5K$368.8K0.25%-$98.7K
EyePoint, Inc.(EYPT)32,50032,5000$259.7K$242.1K0.16%-$17.6K
Biodesix, Inc.(BDSX)28,9160-28,916$51.5K$0—-$51.5K
Myriad Genetics, Inc.(MYGN)134,5000-134,500$3.68M$0—-$3.68M
Page 1 of 1
ORACLE INVESTMENT MANAGEMENT INC — 13F Holdings — Q4 2024 | TickerTrail